All Drug
Common Medicines
Oncology
Hematology
Hepatology
Chronic Diseases
Department of Endocrinology
Orphan drugs
Tumor area
Drug selection
Medical Information
-
Who is suitable for Pemafibrate? Indications and contraindications for populations
Pemafibrate is suitable for specifi...
2026-04-23 17:38:24 -
Pemafibrate side effects: common and serious adverse reactions
When Pemafibrate is used as a lipid...
2026-04-23 17:32:33 -
Who is suitable for Vericiguat? Indications and contraindications for populations
Vericiguat is suitable for specific...
2026-04-22 16:30:42 -
Mechanism of action of Vericiguat: how to improve ejection fraction
Vericiguat is a soluble guanylate c...
2026-04-22 16:27:44 -
Brensoacatib mechanism of action: How to inhibit DPP1 and reduce neutrophil activity?
Brensoacatib regulates neutrophil a...
2026-04-21 14:18:48 -
Brensoacatib: A New Choice for DPP1 Inhibitors in the Treatment of Bronchiectasis
Brensoacatib is a novel dipeptidyl ...
2026-04-21 14:17:29 -
Daclatasvir: Treatment Guidelines for Hepatitis C NS5A Inhibitors
Daclatasvir, as an NS5A inhibitor, ...
2026-04-21 09:27:19 -
Precautions for taking dalatavir: Drug interactions and liver function monitoring
As an antiviral drug for hepatitis ...
2026-04-21 09:25:18